Skip to content

Advertisement

What do you think about BMC? Take part in

Call for papers: Genomics of infection and immunity

Guest Editors: Bali Pulendran and Mark Davis

Infection and ImmunityGenome Medicine is pleased to announce a special issue on Genomics of infection and immunity for publication in Spring 2018, co-guest edited by Bali Pulendran and Mark Davis of Stanford School of Medicine. The issue aims to capture recent advances made using genomic approaches toward understanding the function and diversity of the immune system, regulation of the immune response, and the underlying innate and adaptive mechanisms of host defense against infection. It will also cover pathogen adaptation and evasion strategies, as well as development of approaches to protect against and treat infection.

We are now inviting the submission of Research, Method and Software manuscripts of broad interest describing advances in the genomics of infectious disease and the immune response, in the context of translational and clinical research on the following topics:

  • Mechanisms of host immune response to infection
  • Insights into host susceptibility to infection
  • Systems immunology
  • Immune repertoire analysis and variation of immune response
  • Therapy development (e.g. immunomodulation, broadly neutralizing antibodies)
  • Vaccines
  • Diagnostic strategies
  • Genomic and epigenomic regulation of immune cell subpopulations
  • Mucosal immunity and microbiota
  • Immunometabolism
  • Immunosenescence and aging
  • Mechanisms of pathogenesis (e.g. evasion and regulation of host defense, latency)
  • Regulation of inflammatory responses and autoimmunity
  • Immunological memory

Submission deadline: 28 February 2018

To submit your manuscript, please use Genome Medicine's online submission system and indicate in your covering letter that you would like the article to be considered for the ‘Genomics of infection and immunity’ special issue. If you would like to enquire about the suitability of a manuscript for consideration, please email editorial@genomemedicine.com.

Advertisement